Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Putnak

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Advances in Virus Research|January 13, 2004
Formalin-inactivated whole virus and recombinant subunit flavivirus vaccinesKenneth H Eckels, Robert Putnak
Plos One|April 2, 2016
Recombinant Dengue 2 Virus NS3 Helicase Protein Enhances Antibody and T-Cell Response of Purified Inactivated VaccineMonika Simmons, Peifang Sun, Robert Putnak
Virology|November 17, 2009
Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategyMonika Simmons, Timothy Burgess, Julia Lynch, et al.
Vaccine|September 23, 2008
Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutationsLi Yu, J Robert Putnak, Alexander G Pletnev, et al.
Virus Genes|March 26, 2010
Evidence for inter- and intra-genotypic variations in dengue serotype 4 viruses representing predominant and non-predominant genotypes co-circulating in Thailand from 1977 to 2001Richard Zhao, Piyawan Chinnawirotpisan, Chonticha Klungthong, et al.
The American Journal of Tropical Medicine and Hygiene|September 21, 2016
Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human PrimatesMonika Simmons, Robert Putnak, Peifang Sun, et al.
Tropical Medicine and Infectious Disease|July 3, 2019
Immunological Assays used to Support Efficacy of Zika Virus VaccinesKenneth H Eckels, Rafael A De La Barrera, Joseph Robert Putnak
The American Journal of Tropical Medicine and Hygiene|July 24, 2003
Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genesRobert Putnak, James Fuller, Lorna VanderZanden, et al.
Journal of Virology|September 16, 2006
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaquesMonika Simmons, Kevin R Porter, Curtis G Hayes, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2002
West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacyAlexander G Pletnev, Robert Putnak, Jim Speicher, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Advances in Virus Research|January 13, 2004
Formalin-inactivated whole virus and recombinant subunit flavivirus vaccinesKenneth H Eckels, Robert Putnak
Plos One|April 2, 2016
Recombinant Dengue 2 Virus NS3 Helicase Protein Enhances Antibody and T-Cell Response of Purified Inactivated VaccineMonika Simmons, Peifang Sun, Robert Putnak
Virology|November 17, 2009
Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategyMonika Simmons, Timothy Burgess, Julia Lynch, et al.
Vaccine|September 23, 2008
Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutationsLi Yu, J Robert Putnak, Alexander G Pletnev, et al.
Virus Genes|March 26, 2010
Evidence for inter- and intra-genotypic variations in dengue serotype 4 viruses representing predominant and non-predominant genotypes co-circulating in Thailand from 1977 to 2001Richard Zhao, Piyawan Chinnawirotpisan, Chonticha Klungthong, et al.
The American Journal of Tropical Medicine and Hygiene|September 21, 2016
Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human PrimatesMonika Simmons, Robert Putnak, Peifang Sun, et al.
Tropical Medicine and Infectious Disease|July 3, 2019
Immunological Assays used to Support Efficacy of Zika Virus VaccinesKenneth H Eckels, Rafael A De La Barrera, Joseph Robert Putnak
The American Journal of Tropical Medicine and Hygiene|July 24, 2003
Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genesRobert Putnak, James Fuller, Lorna VanderZanden, et al.
Journal of Virology|September 16, 2006
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaquesMonika Simmons, Kevin R Porter, Curtis G Hayes, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2002
West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacyAlexander G Pletnev, Robert Putnak, Jim Speicher, et al.
Pageof 4